Month: June 2026
How Hearing Loss and Tinnitus “Intertwine” with Cognitive Decline, Diabetes (Hyperinsulinemia), Heart Disease, Diet, Exercise and Noise Excess…An Interview with Kirsten McWilliams, Au.D.
Early Screening, Ear Protection, Reducing the Total Volume, Cardiovascular and Diabetes Prevention and Treatment with Whole Food Diets and Exercise Along with Allergy Control in the Sinuses…
Kirsten McWilliams, Au.D.
Doctor of Audiology
The Hearing Solution
725 University Ave.
Sacramento, CA 95825
(916) 646-2471 office / (916) 646-2472 fax
kirsten@thehearingsolution.com
TheHearingSolution.com
Interview Summary
(Interview transcript below summarized by AI. Reviewed and edited by Kirk Hamilton PA)
In this interview with Kirk Hamilton, PA, Kirsten McWilliams, Au.D., Doctor of Audiology, explains that audiology involves much more than dispensing hearing aids; a Doctor of Audiology completes a four-year clinical doctorate with training in diagnosis and treatment of hearing and balance disorders, hearing technology, prevention, and patient counseling. She emphasizes that hearing care should begin with prevention through baseline testing (generally by age 60 or earlier with risk factors), protection from loud environments, safe listening habits, and early treatment because untreated hearing loss can negatively affect health, communication, relationships, and quality of life. Dr. McWilliams explains that hearing loss is becoming more common due to longer lifespans and increased noise exposure from Continue reading How Hearing Loss and Tinnitus “Intertwine” with Cognitive Decline, Diabetes (Hyperinsulinemia), Heart Disease, Diet, Exercise and Noise Excess…An Interview with Kirsten McWilliams, Au.D.
Precision Medicine for Alzheimer’s Disease and Cognitive Decline..Prevention and Treatment… An Interview with Dale E. Bredesen, MD
“Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible.”
Dale E. Bredesen, MD
Precision Brain Health Program
Pacific Neuro-Science Institute
Santa Monica, CA 90404
Apollohealthco.com
“Precision Medicine Treatment of Alzheimer’s Disease:
Successful Randomized Controlled Trial“
Successful Pilot Project. J Alzheimers Dis. 2022;88(4):1411-1421. PDF
Case Study: A Precision Medicine Approach to Multifactorial Dementia
and Alzheimer’s Disease.
J Alzheimers Dis Parkinsonism. 2021;11(Suppl 5):018. Epub 2021 Aug 25. PDF
ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program
for Reversal of Cognitive Decline.
Biomedicines. 2021 Sep 29;9(10):1348. PDF
Neuroprotective Herbs for the Management of Alzheimer’s Disease.
Biomolecules. 2021 Apr 8;11(4):543.
Reversal of Cognitive Decline in Alzheimer’s Disease.
Aging (Albany NY). 2016 Jun;8(6):1250-8. PDF
Inhalational Alzheimer’s Disease: an Unrecognized – and Treatable – Epidemic.
Aging (Albany NY). 2016 Feb;8(2):304-13. PDF
Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline.
AJNR Am J Neuroradiol. 2015 Oct;36(10):1803-9. PDF
ω-3 Supplementation Increases Amyloid-β phagocytosis
and Resolvin D1 in Patients with Minor Cognitive Impairment.
FASEB J. 2015 Jul;29(7):2681-9.
Reversal of Cognitive Decline: a Novel Therapeutic Program.
Aging (Albany NY). 2014 Sep;6(9):707-17. PDF
__________________________________________________
Books By Dale E. Bredesen, MD
The Ageless Brain: How to Sharpen and Protect Your Mind for a Lifetime
by Dale E. Bredesen MD, March, 2025, 384 pages
The First Survivors of Alzheimer’s: How Patients Recovered Life
and Hope in Their Own Words
Dale Bredesen MD, August, 2021, 272 pages
The End of Alzheimer’s Program: The First Protocol to Enhance Cognition
and Reverse Decline at Any Age
Dale Bredesen, MD, August 18, 2020, 352 pages
The End of Alzheimer’s: The First Program to Prevent and Reverse Cognitive Decline
by Dale Bredesen, MD, August, 2017, 320 pages
_________________________________________________________
(AI generated summary of interview transcript from Kirk Hamilton PA’s interview with Dale E. Bredesen, MD reviewed and edited by interviewer Kirk Hamilton, June 8, 2026)
Precision Medicine Approach to Alzheimer’s Disease & Cognitive Decline
Summary Overview of Interview…
Dr. Dale Bredesen describes Alzheimer’s disease and cognitive decline as a complex systems biology disorder rather than a single amyloid-driven disease. His research suggests that the brain exists in different biological “modes,” especially a connection mode versus a protection mode. In a healthy state, the brain favors synaptic growth, neuronal repair, and communication through pathways Continue reading Precision Medicine for Alzheimer’s Disease and Cognitive Decline..Prevention and Treatment… An Interview with Dale E. Bredesen, MD
Colon Cancer and Tocotrienols Protective Role…What is the Physiology and What is the Evidence… An Interview with Ammu K. Radhakrishnan PhD, MSc
Peer Reviewed Cancer Study – Mebendazole/Ivermectin; Covid Vax & Heart Damage; Brain Health, Marijuana & Youth; Fatty Liver Heart Attack Linked; Depression & Digital Addiction; Heart Function & CoQ10 and More…
Colon Cancer and the Protective Role of Gamma and Delta Tocotrienols (Vitamin E Components) … What is the Physiology and What is the Evidence
Ammu K. Radhakrishnan PhD, MSc
Food as Medicine Research Strength
Jeffrey Cheah School of Medicine and Health Sciences
Monash University Malaysia, 47500 Bandar Sunway, Malaysia
Ammu.radhakrishnan@monash.edu
Insights into the Anticancer Mechanisms Modulated
by Gamma and Delta Tocotrienols in Colorectal Cancers
Nutr Rev. 2025 Mar 1;83(3):e1295-e1310.” (6/2026)
Interview Summary…
In this interview, Dr. Ammu K. Radhakrishnan, Professor of Immunology at Monash University Malaysia, discusses her research on the anticancer potential of gamma- and delta-tocotrienols, lesser-known members of the vitamin E family, particularly in relation to colorectal cancer prevention and adjunctive therapy. Unlike the more commonly recognized alpha-tocopherol form of vitamin E, tocotrienols possess Continue reading Colon Cancer and Tocotrienols Protective Role…What is the Physiology and What is the Evidence… An Interview with Ammu K. Radhakrishnan PhD, MSc
